Results 121 to 130 of about 48,720 (296)

Diabetic Ketoacidosis in Klinefelter Syndrome Sans Malignancy with Unusually Elevated Levels of CEA: A Case Report [PDF]

open access: yes
Xinxin Wo, Xiaoyan Yu, Lingling Miao, Yushan Mao, Keke Tang Department of Endocrinology, The First Affiliated Hospital of Ningbo University, Ningbo University, Ningbo, People’s Republic of ChinaCorrespondence: Keke Tang, Department of Endocrinology, The ...
Tang K, Wo X, Miao L, Yu X, Mao Y
core  

Glucocorticoid-induced Diabetic Ketoacidosis in Acute Rheumatic Fever

open access: yes, 2008
Glucocorticoids are used as anti-inflammatory agents and are associated with many side effects including hyperglycemia, hypertension, pancreatitis, peptic ulcer, and so on. Hyperglycemia is a common side effect, but ketoacidosis is observed rarely.
Pac, F. Aysenur   +2 more
core   +1 more source

Cardiorenal Mortality and Safety Outcomes of GLP‐1 Receptor Agonists in Type 2 Diabetes With BMI Below 27 kg/m2: A Target Trial Emulation

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Cardiorenal evidence for glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) derives mainly from trials in overweight or obesity; data in adults with Type 2 diabetes (T2D) and body mass index (BMI) below 27 kg/m2 are limited. Materials and Methods We emulated a target trial in the TriNetX US Collaborative Network (index dates 2020 to ...
Shao‐Chia Chen   +6 more
wiley   +1 more source

Fejezetek az alkohológia tárgyköréből : 3. Alkoholos ketoacidosis = Chapters from alcohology : 3. Alcoholic ketoacidosis

open access: yes
Az alkoholos ketoacidosis az alkoholfogyasztás és az éhezés metabolikus szövődménye hyperglykaemia nélkül, amelyet alkoholfüggő betegeknél az italozás felfüggesztésekor vagy tivornyázó alkoholfogyasztás után észlelnek.
Kalapos, Miklós Péter   +1 more
core   +1 more source

Increasing Trends in Hospitalisation With Diabetic Ketoacidosis at Type 1 Diabetes Diagnosis Among Children and Youth in the United States and England, 2002–2020

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background There is a paucity of population‐level data evaluating trends in the proportion of children and youth hospitalised with diabetic ketoacidosis (DKA) at the time of Type 1 diabetes (T1D) diagnosis. Methods National Medicaid (US publicly insured claims), MarketScan (US commercially insured claims) and Clinical Practice Research ...
Chintan V. Dave   +6 more
wiley   +1 more source

Fluid Therapy For Pediatric Patients With Diabetic Ketoacidosis: Current Perspectives

open access: yesDiabetes, Metabolic Syndrome and Obesity, 2019
Muralidharan Jayashree, Vijai Williams, Rajalakshmi Iyer Division of Pediatric Emergency and Intensive Care, Department of Pediatrics, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, IndiaCorrespondence:
Jayashree M, Williams V, Iyer R
doaj  

Antenatal Corticosteroids in Gestational Diabetes: A Systematic Review of Glycemic Response and Management Strategies

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background Antenatal corticosteroids (ACS) promote foetal lung maturation in pregnancies at risk of preterm birth; however, in gestational diabetes mellitus (GDM), they can exacerbate maternal glycemia and contribute to adverse neonatal outcomes. Clinical guidelines offer limited direction on optimal treatment adjustment.
Alexandra Katz   +11 more
wiley   +1 more source

Acute brachial artery thrombosis with diabetic ketoacidosis

open access: yes, 2016
Background: Diabetes Mellitus is a worldwide disease that leads to several acute complications including diabetic ketoacidosis. Diabetic ketoacidosis is usually preceded by infection, acute myocardial infarction, stroke, or other dire ...
Syed Abdul Rahman   +2 more
core   +1 more source

Effects of Renin–Angiotensin Inhibitors, Sodium–Glucose Cotransporter 2 Inhibitors, Mineralocorticoid Receptor Antagonists and Glucagon‐Like Peptide 1 Receptor Agonists on Kidney Outcomes in Patients With Type 1 Diabetes: A Systematic Review and Meta‐Analysis

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims While the new kidney protective therapies have transformed chronic kidney disease (CKD) management in patients with Type 2 diabetes mellitus (T2DM), treatment options for CKD in Type 1 diabetes mellitus (T1DM) have remained unchanged for 30 years, limited to renin–angiotensin system inhibitors (RASis).
Frances Perry   +12 more
wiley   +1 more source

Kwasica metaboliczna u dzieci z nowo rozpoznaną cukrzycą typu 1 a czynniki ryzyka kamicy moczowej [PDF]

open access: yesPediatric Endocrinology, Diabetes and Metabolism, 2012
Wprowadzenie: Kamica moczowa jest coraz częściej rozpoznawana u dzieci. Jednymi z głównych czynników ryzyka kamicy są hiprercalciuria, hiperszczawianuria, hipocytraturia oraz stężenie jonów wodorowych mierzonych przy pomocy pH.
Tadeusz Porowski   +4 more
doaj  

Home - About - Disclaimer - Privacy